Financial Health Report: Trevi Therapeutics Inc (TRVI)’s Ratios Tell a Tale

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Trevi Therapeutics Inc (NASDAQ: TRVI) closed the day trading at $3.44 down -1.71% from the previous closing price of $3.50. In other words, the price has decreased by -$1.71 from its previous closing price. On the day, 1.12 million shares were traded. TRVI stock price reached its highest trading level at $3.57 during the session, while it also had its lowest trading level at $3.4.

Ratios:

For a better understanding of TRVI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.68 and its Current Ratio is at 10.68. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

On August 30, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $9.

On August 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $6.H.C. Wainwright initiated its Buy rating on August 30, 2024, with a $6 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 06 ’24 when GOOD JENNIFER L sold 4,219 shares for $3.03 per share. The transaction valued at 12,784 led to the insider holds 213,313 shares of the business.

GOOD JENNIFER L sold 1,840 shares of TRVI for $5,587 on Sep 09 ’24. The President & CEO now owns 213,313 shares after completing the transaction at $3.04 per share. On Sep 05 ’24, another insider, GOOD JENNIFER L, who serves as the President & CEO of the company, sold 40,277 shares for $3.11 each. As a result, the insider received 125,310 and left with 213,313 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TRVI now has a Market Capitalization of 249716160 and an Enterprise Value of 181414192.

Stock Price History:

Over the past 52 weeks, TRVI has reached a high of $4.00, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is 15.77%, while the 200-Day Moving Average is calculated to be 36.89%.

Shares Statistics:

Over the past 3-months, TRVI traded about 240.00K shares per day on average, while over the past 10 days, TRVI traded about 475530 shares per day. A total of 68.28M shares are outstanding, with a floating share count of 46.52M. Insiders hold about 35.92% of the company’s shares, while institutions hold 42.45% stake in the company. Shares short for TRVI as of 1724976000 were 1553644 with a Short Ratio of 6.47, compared to 1722384000 on 1293009. Therefore, it implies a Short% of Shares Outstanding of 1553644 and a Short% of Float of 3.4299999999999997.

Most Popular